Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “KRAS wt Allele”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableStudy completedNCT02597270
What this trial is testing

An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection

Who this might be right for
Hepatitis C Virus
Janssen-Cilag Ltd. 239
Testing effectiveness (Phase 2)Ended earlyNCT02309086
What this trial is testing

Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Clinica Universidad de Navarra, Universidad de Navarra 5
Testing effectiveness (Phase 2)Study completedNCT00606086
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Who this might be right for
Genotype 1 Chronic Hepatitis C
GlobeImmune 140
Not applicableStudy completedNCT01517529
What this trial is testing

Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations

Who this might be right for
Hepatitis C
University of Cincinnati 10
Testing effectiveness (Phase 2)Study completedNCT02125500
What this trial is testing

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

Who this might be right for
Viral Hepatitis CHIV
ANRS, Emerging Infectious Diseases 68
Not applicableUnknownNCT01274208
What this trial is testing

Examining the Immune Response in Patients With Gaucher Disease and Hepatitis C

Who this might be right for
Gaucher DiseaseHepatitis C
Shaare Zedek Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT03119025
What this trial is testing

Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection

Who this might be right for
Hepatitis C, ChronicLiver DiseasesHepatitis+1 more
Russian Academy of Medical Sciences 10
Early research (Phase 1)Study completedNCT00124215
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Versus Placebo for the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C
GlobeImmune 48
Early research (Phase 1)Active Not RecruitingNCT01787500
What this trial is testing

Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Who this might be right for
BRAF NP_004324.2:p.V600XKRAS wt AlleleMetastatic Malignant Solid Neoplasm+4 more
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT01384383
What this trial is testing

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 248